RCOR Insider Trading

Insider Ownership Percentage: 14.40%
Insider Buying (Last 12 Months): $5,007,845.99
Insider Selling (Last 12 Months): $0.00

Renovacor Insider Trading History Chart

This chart shows the insider buying and selling history at Renovacor by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Renovacor Share Price & Price History

Current Price: $2.52
Price Change: +0.30 (1.20%)
As of 10/3/2022 05:32 PM ET

This chart shows the closing price history over time for RCOR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
$130 trillion revolution in this cup?
Former Goldman Sachs executive Nomi Prins recently drank the contents of a brand-new type of battery…

To reveal why 5 billionaires are investing in this tiny $4 company behind it.

And how it could unleash a $130 trillion energy revolution.
Watch the 30-second demo here.

Renovacor Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/18/2022Rtw Investments, LpMajor ShareholderBuy44,440$8.00$355,520.00View SEC Filing Icon  
1/14/2022Rtw Investments, LpMajor ShareholderBuy150,723$8.00$1,205,784.00View SEC Filing Icon  
1/12/2022Rtw Investments, LpMajor ShareholderBuy1,950$7.67$14,956.50View SEC Filing Icon  
1/5/2022Rtw Investments, LpMajor ShareholderBuy100,195$8.00$801,560.00View SEC Filing Icon  
1/3/2022Rtw Investments, LpMajor ShareholderBuy441$7.95$3,505.95View SEC Filing Icon  
12/27/2021Rtw Investments, LpMajor ShareholderBuy4,905$7.99$39,190.95View SEC Filing Icon  
12/22/2021Rtw Investments, LpMajor ShareholderBuy3,500$7.95$27,825.00View SEC Filing Icon  
12/20/2021Rtw Investments, LpMajor ShareholderBuy130,316$7.96$1,037,315.36View SEC Filing Icon  
11/17/2021Rtw Investments, LpMajor ShareholderBuy21,161$9.00$190,449.00View SEC Filing Icon  
11/15/2021Rtw Investments, LpMajor ShareholderBuy4,320$9.01$38,923.20View SEC Filing Icon  
11/11/2021Rtw Investments, LpMajor ShareholderBuy319$8.44$2,692.36View SEC Filing Icon  
11/8/2021Rtw Investments, LpMajor ShareholderBuy100,009$8.25$825,074.25View SEC Filing Icon  
11/4/2021Rtw Investments, LpMajor ShareholderBuy57,914$8.03$465,049.42View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Renovacor (NYSE:RCOR)

45.84% of Renovacor stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RCOR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Renovacor Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/12/2022Ikarian Capital LLC293,283$0.60M0.1%-14.6%1.698%Search for SEC Filing on Google Icon
5/16/2022State Street Corp11,829$50K0.0%N/A0.069%Search for SEC Filing on Google Icon
5/6/2022New Leaf Venture Partners L.L.C.672,288$2.85M1.4%-3.6%3.896%Search for SEC Filing on Google Icon
11/15/2021683 Capital Management LLC175,000$1.58M0.1%N/A1.014%Search for SEC Filing on Google Icon
11/12/2021New Leaf Venture Partners L.L.C.697,436$6.31M1.8%N/A4.042%Search for SEC Filing on Google Icon
11/12/2021Cowen AND Company LLC10,000$91K0.0%N/A0.058%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Renovacor logo
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). The company's lead product candidate is REN-001, a recombinant adeno-associated virus 9-based gene therapy designed to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes, and slow or halt progression of BAG3 DCM. It is also developing a pipeline of BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function. The company was founded in 2013 and is based in Greenwich, Connecticut.
Read More on Renovacor

Today's Range

Now: $2.52
Low: $2.45
High: $2.73

50 Day Range

MA: $1.88
Low: $1.64
High: $2.52

52 Week Range

Now: $2.52
Low: $1.34
High: $9.74

Volume

38,500 shs

Average Volume

30,390 shs

Market Capitalization

$43.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Renovacor?

Renovacor's top insider shareholders include:
  1. Rtw Investments, Lp (Major Shareholder)
Learn More about top insider investors at Renovacor.